SPRIM has more than 450 people in 17 offices across six continents. We focus on discovering and implementing new ideas to deliver better health. Large multi-national companies, startups, institutions, and governments around the world turn to us for help developing relevant, fresh and meaningful health innovations. From traditional categories like nutrition, cosmetics, personal care and pharmaceuticals to the new health frontier of digital-connected devices and algorithm-based diagnostics, we work to deliver winning health solutions and tangible commercial results. In 2017, SPRIM and Tikehau Capital launched TKS 1, a venture capital fund designed to support early-stage, healthcare tech companies. TKS 1 provides capital to innovative companies offering solutions that move science forward in the health sector, contribute to the transition from intervention to prediction, and enable life science companies globally to develop therapeutics faster and more economically.